Literature DB >> 29268358

Histologic subtype component predicts lymph node micrometastasis and prognosis in patients with stage I lung adenocarcinoma.

Jung-Jyh Hung1.   

Abstract

Entities:  

Year:  2017        PMID： 29268358      PMCID： PMC5723780          DOI： 10.21037/jtd.2017.09.129

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  20 in total

1.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

2.  Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller.

Authors:  Jung-Jyh Hung; Yi-Chen Yeh; Yu-Chung Wu; Teh-Ying Chou; Wen-Hu Hsu
Journal:  J Thorac Oncol       Date:  2017-07-21       Impact factor: 15.609

3.  The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival.

Authors:  Arne Warth; Thomas Muley; Michael Meister; Albrecht Stenzinger; Michael Thomas; Peter Schirmacher; Philipp A Schnabel; Jan Budczies; Hans Hoffmann; Wilko Weichert
Journal:  J Clin Oncol       Date:  2012-03-05       Impact factor: 44.544

4.  International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification predicts occult lymph node metastasis in clinically mediastinal node-negative lung adenocarcinoma.

Authors:  Yi-Chen Yeh; Kyuichi Kadota; Jun-ichi Nitadori; Camelia S Sima; Nabil P Rizk; David R Jones; William D Travis; Prasad S Adusumilli
Journal:  Eur J Cardiothorac Surg       Date:  2015-09-15       Impact factor: 4.191

5.  Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.

Authors:  Jung-Jyh Hung; Yi-Chen Yeh; Wen-Juei Jeng; Kou-Juey Wu; Biing-Shiun Huang; Yu-Chung Wu; Teh-Ying Chou; Wen-Hu Hsu
Journal:  J Clin Oncol       Date:  2014-05-05       Impact factor: 44.544

6.  Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.

Authors:  Gail E Darling; Mark S Allen; Paul A Decker; Karla Ballman; Richard A Malthaner; Richard I Inculet; David R Jones; Robert J McKenna; Rodney J Landreneau; Valerie W Rusch; Joe B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03       Impact factor: 5.209

7.  Prognostic value of the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society lung adenocarcinoma classification on death and recurrence in completely resected stage I lung adenocarcinoma.

Authors:  Jung-Jyh Hung; Wen-Juei Jeng; Teh-Ying Chou; Wen-Hu Hsu; Kou-Juey Wu; Biing-Shiun Huang; Yu-Chung Wu
Journal:  Ann Surg       Date:  2013-12       Impact factor: 12.969

8.  Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung.

Authors:  Lauren Xu; Fabio Tavora; Allen Burke
Journal:  Am J Surg Pathol       Date:  2013-07       Impact factor: 6.394

9.  Factors predicting occult lymph node metastasis in completely resected lung adenocarcinoma of 3 cm or smaller.

Authors:  Jung-Jyh Hung; Yi-Chen Yeh; Wen-Juei Jeng; Yu-Chung Wu; Teh-Ying Chou; Wen-Hu Hsu
Journal:  Eur J Cardiothorac Surg       Date:  2016-01-27       Impact factor: 4.191

10.  Minor Components of Micropapillary and Solid Subtypes in Lung Adenocarcinoma are Predictors of Lymph Node Metastasis and Poor Prognosis.

Authors:  Yue Zhao; Rui Wang; Xuxia Shen; Yunjian Pan; Chao Cheng; Yuan Li; Lei Shen; Yang Zhang; Hang Li; Difan Zheng; Ting Ye; Shanbo Zheng; Yihua Sun; Haiquan Chen
Journal:  Ann Surg Oncol       Date:  2016-02-02       Impact factor: 5.344
View more
  2 in total

1.  Prognostic and diagnostic significance of Cavin 2 in lung adenocarcinoma.

Authors:  Xianguo Wang; Diana Maria Cespedes Arcani; Jingping Zhao; Ming Xu; Xuefeng Zhou; Yibin Yang
Journal:  Arch Med Sci       Date:  2019-05-24       Impact factor: 3.318

2.  Targeted Sequencing Analysis of Predominant Histological Subtypes in Resected Stage I Invasive Lung Adenocarcinoma.

Authors:  Yan Li; Yan Tan; Song Hu; Jun Xie; Zhantao Yan; Xian Zhang; Yun Zong; Han Han-Zhang; Qing Li; Chong Li
Journal:  J Cancer       Date:  2021-04-02       Impact factor: 4.207
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.